¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) ±¹¸³¾Ï¼¾ÅÍ ¾Ï°úÇÐÆ÷·³, Ç׾Ͻžళ¹ß A-Z, Part 3. »õ·Î¿î Ç×¾ÏÀü·«: ¼±ÅÃÀû ´Ü¹éÁú ºÐÇØ (New Strategy against Cancer: Targeted Protein Degradation) : 2022-03-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) ±¹¸³¾Ï¼¾ÅÍ ¾Ï°úÇÐÆ÷·³, Ç׾Ͻžళ¹ß A-Z, Part 3. »õ·Î¿î Ç×¾ÏÀü·«: ¼±ÅÃÀû ´Ü¹éÁú ºÐÇØ (New Strategy against Cancer: Targeted Protein Degradation) : 2022-03-04
±³À°ÀÏÀÚ : 2022-03-04
±³À°Àå¼Ò : ±¹¸³¾Ï¼¾ÅÍ °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) ±¹¸³¾Ï¼¾ÅÍ ¾Ï°úÇÐÆ÷·³, Ç׾Ͻžళ¹ß A-Z, Part 3. »õ·Î¿î Ç×¾ÏÀü·«: ¼±ÅÃÀû ´Ü¹éÁú ºÐÇØ (New Strategy against Cancer: Targeted Protein Degradation)
ÁÖÃÖ±â°ü : ±¹¸³¾Ï¼¾ÅÍ
´ã´çÀÚ : ¹Ú¼ö¿¬
¿¬¶ôó : 031-920-0037  
À̸ÞÀÏ : chungga96@ncc.re.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¹æ»ç¼±Á¾¾çÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 03-04 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 13:30~13:35 °³È¸»ç  ±è¿µ¿ì(±¹¸³¾Ï¼¾ÅÍ ¿¬±¸¼ÒÀå) 
±âŸ 03-04 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 13:35~13:40 Ãà»ç  ¼­È«°ü(±¹¸³¾Ï¼¾ÅÍ ¿øÀå) 
±³À°½Ã°£ 03-04 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 13:40~14:10 Targeted Protein Degradation Technology: Opportunities and Challenges  È²Á¾¿¬(Çѱ¹È­Çבּ¸¿ø) 
±³À°½Ã°£ 03-04 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 14:10~14:40 PROTAC as a Promising Therapeutic Modality against Cancer  ½Éź¸(¿¬¼¼´ëÇб³) 
±³À°½Ã°£ 03-04 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 14:40~15:10 Targeted Protein Degradation through the N-Degron Pathway  ÀÓÇö¼®(Æ÷Ç×°ø°ú´ëÇб³) 
È޽Ġ03-04 °ËÁøµ¿ 9Ãþ ±¹Á¦È¸ÀÇÀå 15:10~15:30 È޽Ġ () 
±³À°½Ã°£ 03-04 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 15:30~16:00 Emerging Platform Technologies including Bio-PROTAC in Targeted Protein Degradation  ¼­º¸±¤(¢ßÀ¯ºò½ºÅ׶óǻƽ½º(Ubix Therapeutics)) 
±³À°½Ã°£ 03-04 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 16:00~16:30 The AUTOTAC Chemical Biology Platform in Drug Development for Targeted Degradation via the Autophagy-Lysosome System  ±Ç¿ëÅÂ(¼­¿ï´ëÇб³) 
±³À°½Ã°£ 03-04 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 16:30~17:00 Molecular Glue Degrader, the Way of Strategic Approaches  Á¶Çö¼±(¢ßÇÉÅ׶óǻƽ½º(Pin Therapeutics)) 
±âŸ 03-04 °ËÁøµ¿ 8Ãþ ±¹Á¦È¸ÀÇÀå 17:00~17:05 Æóȸ»ç  ±è¿µ¿ì(±¹¸³¾Ï¼¾ÅÍ ¿¬±¸¼ÒÀå) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2022 ¹Ì´Ï½ÉÆ÷Áö¾ö : 2022-03-04
´ÙÀ½±Û Á¦ 252Â÷ ´ëÇÑ ÇǺΰúÇÐȸ ´ë±¸°æºÏÁöºÎ Áý´ãȸ : 2022-03-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 6 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 10 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 11 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 9 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 10 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 5 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 3 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 5 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 4 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 5 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 3 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 11 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 3 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 8 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 4 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷